T
NVO

Tidemark’s Novo Nordisk NVO Stock Holding History

Tidemark’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.7K Buy
808
+61
+8% +$2.62K 0.01% 334
2026
Q1 		$27.5K Buy
747
+597
+398% +$28.3K 0.01% 331
2025
Q4 		$7.63K Sell
150
-20
-12% -$1.02K ﹤0.01% 455
2025
Q3 		$9.44K Hold
170
– – ﹤0.01% 464
2025
Q2 		$11.7K Buy
170
+20
+13% +$1.36K ﹤0.01% 431
2025
Q1 		$10.4K Hold
150
– – ﹤0.01% 431
2024
Q4 		$12.9K Sell
150
-150
-50% -$16.2K ﹤0.01% 403
2024
Q3 		$35.7K Hold
300
– – 0.01% 278
2024
Q2 		$42.8K Hold
300
– – 0.02% 236
2024
Q1 		$38.5K Hold
300
– – 0.02% 267
2023
Q4 		$31K Buy
+300
New +$29.7K 0.02% 279

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Tidemark's NVO Position: Q2 2026 in Review

Tidemark increased its Novo Nordisk (NVO) stake by 8.2% in Q2 2026, buying an estimated $2.62K and bringing the position to 808 shares worth $38.7K. The position accounts for 0.01% of the portfolio, ranked #334.

Tidemark first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $42.8K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Tidemark held 808 shares of Novo Nordisk worth $38.7K as of Q2 2026.
  • Tidemark bought 61 Novo Nordisk shares in Q2 2026, an estimated $2.62K.
  • Novo Nordisk made up 0.01% of Tidemark's portfolio in Q2 2026, its #334 holding.
  • Tidemark first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's Novo Nordisk position peaked at $42.8K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.